Max Planck Publications of Meissner Lab
The following publications were published exclusively under the affiliation of the Max Planck Society. For publications by the principal investigator outside of the Max Planck Society, see the links on the lower left.
Journal Article (12)
Journal Article
81 (24), pp. 6117 - 6130 (2021)
Activation of Notch and Myc Signaling via B-cell-Restricted Depletion of Dnmt3a Generates a Consistent Murine Model of Chronic Lymphocytic Leukemia. Cancer Research
Journal Article
37 (6), 109967 (2021)
Chromatin-state barriers enforce an irreversible mammalian cell fate decision. Cell Reports
Journal Article
56 (21), pp. 2995 - 3005 (2021)
Diverse epigenetic mechanisms maintain parental imprints within the embryonic and extraembryonic lineages. Developmental Cell
Journal Article
37 (21), pp. 3934 - 3935 (2021)
RLM: Fast and simplified extraction of Read-Level Methylation metrics from bisulfite sequencing data. Bioinformatics
Journal Article
16, pp. 4004 - 4030 (2021)
Smart-RRBS for single-cell methylome and transcriptome analysis. Nature Protocols
Journal Article
35 (17-18), pp. 1209 - 1228 (2021)
Dissecting dual roles of MyoD during lineage conversion to mature myocytes and myogenic stem cells. Genes and Development
Journal Article
12 (1), Article 4897 (2021)
Topological isolation of developmental regulators in mammalian genomes. Nature Communications
Journal Article
28 (7), pp. 594 - 603 (2021)
Dnmt1 has de novo activity targeted to transposable elements. Nature Structural and Molecular Biology
Journal Article
11 (11), e4042 (2021)
Generation of Mouse Pluripotent Stem Cell-derived Trunk-like Structures: An in vitro Model of Post-implantation Embryogenesis. Bio-protocol
Journal Article
372 (6543), pp. 716 - 721 (2021)
Cell-specific transcriptional control of mitochondrial metabolism by TIF1γ drives erythropoiesis. Science
Journal Article
11 (9), pp. 2266 - 2281 (2021)
Discovery of candidate DNA methylation cancer driver genes. Cancer Discovery
Journal Article
2 (1), pp. 54 - 69 (2021)
Pre-neoplastic alterations define CLL DNA methylome and persist through disease progression and therapy. Blood Cancer Discovery